Correlation Between Pmv Pharmaceuticals and Scisparc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Scisparc, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Scisparc.

Diversification Opportunities for Pmv Pharmaceuticals and Scisparc

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Pmv and Scisparc is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Scisparc go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Scisparc

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 16.53 times less return on investment than Scisparc. But when comparing it to its historical volatility, Pmv Pharmaceuticals is 2.18 times less risky than Scisparc. It trades about 0.02 of its potential returns per unit of risk. Scisparc is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  24.00  in Scisparc on August 24, 2024 and sell it today you would earn a total of  5.00  from holding Scisparc or generate 20.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Scisparc

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Scisparc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scisparc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pmv Pharmaceuticals and Scisparc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Scisparc

The main advantage of trading using opposite Pmv Pharmaceuticals and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.
The idea behind Pmv Pharmaceuticals and Scisparc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data